- Home
- XXII vs FUSEW Comparison
XXII vs FUSEW Comparison
Compare XXII & FUSEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XXII
- FUSEW
- Stock Information
- Founded
- XXII 1998
- FUSEW N/A
- Country
- XXII United States
- FUSEW United States
- Employees
- XXII N/A
- FUSEW N/A
- Industry
- XXII Medicinal Chemicals and Botanical Products
- FUSEW EDP Services
- Sector
- XXII Health Care
- FUSEW Technology
- Exchange
- XXII Nasdaq
- FUSEW Nasdaq
- Market Cap
- XXII 6.2M
- FUSEW 5.4M
- IPO Year
- XXII N/A
- FUSEW N/A
- Fundamental
- Price
- XXII $1.67
- FUSEW $0.21
- Analyst Decision
- XXII
- FUSEW
- Analyst Count
- XXII 0
- FUSEW 0
- Target Price
- XXII N/A
- FUSEW N/A
- AVG Volume (30 Days)
- XXII 341.7K
- FUSEW N/A
- Earning Date
- XXII 11-04-2025
- FUSEW N/A
- Dividend Yield
- XXII N/A
- FUSEW N/A
- EPS Growth
- XXII N/A
- FUSEW N/A
- EPS
- XXII N/A
- FUSEW N/A
- Revenue
- XXII $21,362,000.00
- FUSEW N/A
- Revenue This Year
- XXII N/A
- FUSEW N/A
- Revenue Next Year
- XXII $126.57
- FUSEW N/A
- P/E Ratio
- XXII N/A
- FUSEW N/A
- Revenue Growth
- XXII N/A
- FUSEW N/A
- 52 Week Low
- XXII $1.43
- FUSEW N/A
- 52 Week High
- XXII $394.02
- FUSEW N/A
- Technical
- Relative Strength Index (RSI)
- XXII 52.22
- FUSEW N/A
- Support Level
- XXII $1.48
- FUSEW N/A
- Resistance Level
- XXII $1.62
- FUSEW N/A
- Average True Range (ATR)
- XXII 0.09
- FUSEW 0.00
- MACD
- XXII 0.03
- FUSEW 0.00
- Stochastic Oscillator
- XXII 65.57
- FUSEW 0.00
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.